MARC details
000 -LEADER |
fixed length control field |
05578nam a22006017a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
221018s20222022 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1075-122X |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1155/2022/1389539 [doi] |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
PMC9453011 [pmc] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
36105366 |
245 ## - TITLE STATEMENT |
Title |
Bacitracin for Injection Recall: Impact on Immediate Breast Implant Surgical Outcomes. |
251 ## - Source |
Source |
Breast Journal. 2022:1389539, 2022. |
252 ## - Abbreviated Source |
Abbreviated source |
Breast J. 2022:1389539, 2022. |
253 ## - Journal Name |
Journal name |
The breast journal |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2022 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2023 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Publication status |
epublish |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Medline status |
MEDLINE |
266 ## - Date added to catalog |
Date added to catalog |
2022-10-20 |
520 ## - SUMMARY, ETC. |
Abstract |
Background: Triple-antibiotic irrigation of breast implant pockets is a mainstay of infection prophylaxis in breast reconstruction and augmentation. The recall of bacitracin for injection due to risk of anaphylaxis and nephrotoxicity in January 2020, a staple component of the irrigation solution, has raised concern for worsened postoperative sequelae. This study aimed to investigate pre- and post-recall implant-based breast surgery to analyze the impact of bacitracin in irrigation solutions on infection rates. |
520 ## - SUMMARY, ETC. |
Abstract |
Conclusions: Despite the recent recall of bacitracin from inclusion in breast pocket irrigation solutions, our study demonstrated no detrimental impact on immediate complication rates. This shift in irrigation protocols calls for additional investigations into optimizing antibiotic combinations in solution, as bacitracin is no longer a viable option, to improve surgical outcomes and long-term benefits. Copyright © 2022 Abigail R. Tirrell et al. |
520 ## - SUMMARY, ETC. |
Abstract |
Methods: All implant-based breast reconstruction or augmentation surgeries from January 2019 to February 2021 were retrospectively reviewed. In a regression discontinuity study design, patients were divided into pre- and post-recall groups. Patient demographics, surgical details, and outcomes including infection rates were collected. Differences in complication rates were compared between groups and with surgical and patient factors. |
520 ## - SUMMARY, ETC. |
Abstract |
Results: 254 implants in 143 patients met inclusion criteria for this study, with 172 implants placed before recall and 82 placed after recall. Patients in each cohort did not differ in age, BMI, smoking status, or history of breast radiation or capsular contracture (p > 0.05). All breast pockets were irrigated with antibiotic solution, most commonly bacitracin, cefazolin, gentamycin, and povidone-iodine before recall (116,67.4%) and cefazolin, gentamycin, and povidone-iodine after recall (59,72.0%). There was no difference in incidence of infection (6.4% vs. 8.5%, p=0.551) or cellulitis (3.5% vs. 3.7%, p=0.959) before and after recall. Implant infection was associated with smoking history (p < 0.001) and increased surgical time (p=0.003). |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Breast Implants |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Breast Neoplasms |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Anti-Bacterial Agents/ae [Adverse Effects] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Bacitracin/ae [Adverse Effects] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Breast Neoplasms/dt [Drug Therapy] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cefazolin |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Female |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Gentamicins |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Humans |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Povidone-Iodine/tu [Therapeutic Use] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Retrospective Studies |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Treatment Outcome |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Health Research Institute |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Washington Hospital Center |
656 ## - INDEX TERM--OCCUPATION |
Department |
MedStar Georgetown University Hospital/MedStar Washington Hospital Center |
656 ## - INDEX TERM--OCCUPATION |
Department |
Plastic Surgery Residency |
656 ## - INDEX TERM--OCCUPATION |
Department |
Surgery/Plastic Surgery |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Journal Article |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Bekeny, Jenna |
Institution Code |
MGUH |
Program |
Plastic Surgery Residency |
Degree |
MD |
Resident year |
Resident PGY 2 |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Fan, Kenneth L |
Institution Code |
MWHC |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Tefera, Eshetu A |
Institution Code |
MHRI |
790 ## - Authors |
All authors |
Bekeny JC, Fan KL, Song DH, Tefera EA, Tirrell AR |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.1155/2022/1389539">https://dx.doi.org/10.1155/2022/1389539</a> |
Public note |
https://dx.doi.org/10.1155/2022/1389539 |
858 ## - ORCID |
ORCID text |
Bekeny, Jenna C |
-- |
Fan, Kenneth L |
-- |
Tefera, Eshetu A |
Orcid |
<a href="https://orcid.org/0000-0002-7517-4326">https://orcid.org/0000-0002-7517-4326</a> |
-- |
<a href="https://orcid.org/0000-0001-5951-5576">https://orcid.org/0000-0001-5951-5576</a> |
-- |
<a href="https://orcid.org/0000-0001-5041-8438">https://orcid.org/0000-0001-5041-8438</a> |
Name |
https://orcid.org/0000-0002-7517-4326 |
-- |
https://orcid.org/0000-0001-5951-5576 |
-- |
https://orcid.org/0000-0001-5041-8438 |
-- |
https://orcid.org/0000-0002-7517-4326 |
-- |
https://orcid.org/0000-0001-5951-5576 |
-- |
https://orcid.org/0000-0001-5041-8438 |
-- |
https://orcid.org/0000-0002-7517-4326 |
-- |
https://orcid.org/0000-0001-5951-5576 |
-- |
https://orcid.org/0000-0001-5041-8438 |
858 ## - ORCID |
ORCID text |
Bekeny, Jenna C |
-- |
Fan, Kenneth L |
-- |
Tefera, Eshetu A |
Orcid |
<a href="https://orcid.org/0000-0002-7517-4326">https://orcid.org/0000-0002-7517-4326</a> |
-- |
<a href="https://orcid.org/0000-0001-5951-5576">https://orcid.org/0000-0001-5951-5576</a> |
-- |
<a href="https://orcid.org/0000-0001-5041-8438">https://orcid.org/0000-0001-5041-8438</a> |
Name |
https://orcid.org/0000-0002-7517-4326 |
-- |
https://orcid.org/0000-0001-5951-5576 |
-- |
https://orcid.org/0000-0001-5041-8438 |
-- |
https://orcid.org/0000-0002-7517-4326 |
-- |
https://orcid.org/0000-0001-5951-5576 |
-- |
https://orcid.org/0000-0001-5041-8438 |
-- |
https://orcid.org/0000-0002-7517-4326 |
-- |
https://orcid.org/0000-0001-5951-5576 |
-- |
https://orcid.org/0000-0001-5041-8438 |
858 ## - ORCID |
ORCID text |
Bekeny, Jenna C |
-- |
Fan, Kenneth L |
-- |
Tefera, Eshetu A |
Orcid |
<a href="https://orcid.org/0000-0002-7517-4326">https://orcid.org/0000-0002-7517-4326</a> |
-- |
<a href="https://orcid.org/0000-0001-5951-5576">https://orcid.org/0000-0001-5951-5576</a> |
-- |
<a href="https://orcid.org/0000-0001-5041-8438">https://orcid.org/0000-0001-5041-8438</a> |
Name |
https://orcid.org/0000-0002-7517-4326 |
-- |
https://orcid.org/0000-0001-5951-5576 |
-- |
https://orcid.org/0000-0001-5041-8438 |
-- |
https://orcid.org/0000-0002-7517-4326 |
-- |
https://orcid.org/0000-0001-5951-5576 |
-- |
https://orcid.org/0000-0001-5041-8438 |
-- |
https://orcid.org/0000-0002-7517-4326 |
-- |
https://orcid.org/0000-0001-5951-5576 |
-- |
https://orcid.org/0000-0001-5041-8438 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |